Latest Blog Posts Tagged "Research Grants"
March 22, 2018
The Michael J. Fox Foundation is funding three teams to look across environmental and genetic factors and aging to understand Parkinson's onset and progression.
November 20, 2017
Foundation-funded research lays groundwork to deepen understanding of Parkinson's and speed breakthroughs.
September 19, 2016
MJFF awarded a $1 million grant to researchers at The Virginia Commonwealth University who have developed a non-invasive eye test that could potentially diagnose Parkinson's disease.
August 24, 2016
To keep you informed of the Foundation's research investments, we're highlighting a few newly funded grants supporting the development of therapies to address common non-motor symptoms of Parkinson's.
September 01, 2015
Based on findings from MJFF-funded research, today the Parkinson Study Group announced an NIH grant for a Phase III trial of inosine, a potential disease-modifying treatment for Parkinson's disease.
August 14, 2015
Neuropore Therapies and Biogen grow the field of clinical trials with approaches against alpha-synuclein, our most promising target for a therapy to slow or stop Parkinson's progression.
July 27, 2015
Tanya Simuni, MD, spoke to us about results from a trial of diabetes drug pioglitazone for PD treatment and what her team's findings mean for this vein of Parkinson's research.
May 29, 2015
Earlier this year MJFF launched two programs investigating the unknowns around alpha-synuclein, our most promising target for a disease-modifying therapy.
April 10, 2015
A number of recent grants went to research projects exploring new avenues that may be the key to stopping Parkinson's progression.
February 06, 2015
MJFF selects awardees for 2014 second half Partnering Program